GlassScriptPhysician profile
Hannah I Chaudry
NPI 1043621113
$19,838.30
in general payments reported to CMS, 2019-2025
13 companies · $13K in 2025
The $13K reported for 2025 was more than what 90% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,124 · 2021: $1,147 · 2022: $1,771 · 2023: $262 · 2024: $2,526 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,000 · Food and Beverage: $4,011 · Travel and Lodging: $2,746 · Education: $38.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,000.00 |
| Food and Beverage | $4,011.26 |
| Travel and Lodging | $2,746.20 |
| Education | $38.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cordis US Corp. | $10,931.95 | 2025 | Selution Slr Pta |
| Medtronic, INC. | $4,125.37 | 2021-2025 | Onyx Frontier, Resolute Onyx, Abre |
| Medtronic Vascular, INC. | $1,124.49 | 2020 | |
| Boston Scientific Corporation | $1,087.29 | 2021-2025 | Avvigo Guidance System, General - Atherectomy, General - Therapies |
| Asahi Intecc USA, INC. | $885.78 | 2022-2025 | Asahi Coronary Wires, Peripheral Vascular, Asahi Peripheral Vascular Wires |
| Abiomed | $815.86 | 2024-2025 | Impella |
| Teleflex LLC | $431.47 | 2024-2025 | Guideliner, Turnpike |
| Verge Medical, INC. | $225.87 | 2024 | |
| Philips North America LLC | $71.57 | 2022 | |
| Reflow Medical INC | $63.45 | 2024 | |
| Novo Nordisk INC | $32.27 | 2025 | Ozempic |
| Edwards Lifesciences Corporation | $24.60 | 2023 | Sapien 3 Ultra Resilia |
| Shockwave Medical, INC | $18.33 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Chaudry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.